NCT00662350View on ClinicalTrials.gov

Temperature Mapping of the Prostate With the Wallterm™ System

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

August 31, 2009

Conditions
Benign Prostatic Hyperplasia
Interventions
DEVICE

The Wallterm™ System

The Wallterm™ System is intended to ablate prostatic glandular and stromal tissue to relieve moderate to severe symptoms of outflow obstruction secondary to benign prostatic hyperplasia (BPH).

Trial Locations (1)

2730

Herlev Hospital, Herlev

Sponsors

Lead Sponsor

Pnn Medical A/S
All Listed Sponsors
lead

Pnn Medical A/S

INDUSTRY